STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
Year: 2015
Type: review
Abstract: Signal transducer and activator of transcription (STAT)3 mediates the signaling downstream of cytokine and growth factor receptors, regulating the expression of target genes. It is constitutively phosphorylated on tyrosine (Y-P) in many tumors, where its transcriptional activity can induce a metabolic switch toward aerobic glycolysis and down-regulate mitochondrial activity, a prominent metabolic feature of most cancer cells, correlating with reduced production of ROS, delayed senescence, and protection from apoptosis. STAT3 can, however, also localize to mitochondria, where its serine-phosphorylated (S-P) form preserves mitochondrial oxidative phosphorylation and controls the opening of the mitochondrial permeability transition pore, also promoting survival and resistance to apoptosis in response to specific signals/oncogenes such as RAS. Thus, downstream of different signals, both nuclear, Y-P STAT3, and mitochondrial, S-P STAT3, can act by promoting cell survival and reducing ROS production. Here, we discuss these properties in the light of potential connections between STAT3-driven alterations of mitochondrial metabolism and the development of drug resistance in cancer patients.
Source: Frontiers in Oncology
Authors: Valeria Poli, Annalisa Camporeale
Institution: University of Turin
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: STAT3, metabolic reprogramming, aerobic glycolysis, mitochondrial metabolism, serine phosphorylation, tyrosine phosphorylation, mitochondrial permeability transition pore, reactive oxygen species, apoptosis resistance, cellular senescence, Ras signaling, drug resistance, tumor cell survival
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W1552924550
